Health care providers should know the symptoms of acute flaccid myelitis and immediately hospitalize those who exhibit them, the Centers for Disease Control today said.

AFM mostly affects children and can progress rapidly over the course of hours or days, leading to permanent paralysis and respiratory failure in previously healthy patients. CDC said AFM tends to come in two-year cycles, with the last peak occurring in 2018, hence its new report to provide an anticipatory alert and vital information in preparation of an outbreak this year.

“All clinicians should remain vigilant for AFM and promptly evaluate patients,” said Thomas Clark, M.D., deputy director of CDC’s Division of Viral Diseases. “During the COVID-19 pandemic, this may require adjusting practices to perform clinical evaluations of patients by phone or telemedicine.”

Using 2018 data, the report shows that 98% of AFM patients required hospitalization; 54% were admitted to an intensive care unit and 1 in 4 hospitalized patients needed mechanical ventilation. CDC Director Robert R. Redfield, M.D., in a news briefing today said clinicians should act to prevent worse outcomes by not delaying patients’ hospitalizations.

Related News Articles

Headline
AHA podcast: Food as Medicine — How Cleveland Clinic Is Nourishing Community HealthVickie Johnson, executive vice president and chief community officer at…
Headline
As part of Community Health Improvement Week June 9-13, two experts from Corewell Health share how an impactful health care ecosystem model is supporting local…
Headline
With June 9-13 being Community Health Improvement Week, three experts from HonorHealth discuss how the health care network is addressing community needs beyond…
Blog
Even before the COVID pandemic, the mental health and wellness of our young people was failing. The pandemic exacerbated the crisis and made it difficult for…
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…